Trials / Unknown
UnknownNCT05849324
Intravascular Injection Rate During Lumbar Transforaminal Epidural Block Using Bent or Straight Needles
The Difference of Intravascular Injection Rate During Lumbar Transforaminal Epidural Block Using Bent Needle Compared to Straight Needle: a Prospective Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 260 (estimated)
- Sponsor
- Kyungpook National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The primary aim of this study was to compare intravascular injection rates during LTFESI between commonly used straight and bent chiba needles.
Detailed description
Lumbar transforaminal epidural steroid injection (LTFESI) is widely used in clinical practice to effectively deliver injectate into the ventral epidural space. Complications associated with intravascular injection such as spinal cord infarction and paraplegia can occur during LTFESI. The incidence of intravascular injection during LTFESI was known as 9.9% \~ 17.7%. To improve the safety of the procedure, avoidance of intravascular injection is crucial, for which appropriate needle selection is important. Currently, the most commonly used block needles in LTFESI are straight or bent chiba needles. The primary aim of this study was to compare intravascular injection rates during LTFESI between commonly used straight and bent chiba needles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Straight needle | Lumbar transforaminal epidural steroid injection is a useful option in the diagnosis and treatment of lumbar radicular pain. During lumbar transforaminal epidural steroid injection, straight needle is going to be used. |
| DEVICE | Bent needle | Lumbar transforaminal epidural steroid injection is a useful option in the diagnosis and treatment of lumbar radicular pain. During lumbar transforaminal epidural steroid injection, bent needle is going to be used. |
Timeline
- Start date
- 2023-04-27
- Primary completion
- 2023-11-30
- Completion
- 2023-12-31
- First posted
- 2023-05-08
- Last updated
- 2023-05-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05849324. Inclusion in this directory is not an endorsement.